[
    [
        {
            "time": "",
            "original_text": "安图生物(603658.SH)披露定增结果：UBS AG获配约12.92亿元 Goldman Sachs及J.P. Morgan均参与",
            "features": {
                "keywords": [
                    "安图生物",
                    "定增",
                    "UBS AG",
                    "Goldman Sachs",
                    "J.P. Morgan"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "安图生物(603658.SH)披露定增结果：UBS AG获配约12.92亿元 Goldman Sachs及J.P. Morgan均参与",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医疗健康产业2021年投资策略：医疗投资迎来长跑期 关注医保控费下的新机遇",
            "features": {
                "keywords": [
                    "医疗健康",
                    "投资策略",
                    "医保控费",
                    "新机遇"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗健康产业2021年投资策略：医疗投资迎来长跑期 关注医保控费下的新机遇",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医药行业周报：冠脉支架拟中标结果发布 辉瑞／BIONTECH发布疫苗积极结果",
            "features": {
                "keywords": [
                    "医药行业",
                    "冠脉支架",
                    "拟中标",
                    "辉瑞",
                    "BIONTECH",
                    "疫苗",
                    "积极结果"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报：冠脉支架拟中标结果发布 辉瑞／BIONTECH发布疫苗积极结果",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]